McGill University will launch an ambitious effort to advance understanding of the human brain and ease the burden of neurological and mental-health disorders, thanks to an $84 million, seven-year grant announced today under the federal government's Canada First Excellence Research Fund (CFREF).
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.
Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.
Using genetic analysis, the team of researchers found rare variations of one gene, RNF213, that appeared more frequently in IA patients than in the control group. Both patients and the control group came from French-Canadian families.
In conjunction with Open Access Week and Homecoming, 135 years of McGill graduate scholarship is now available online! Years in the making, the electronic thesis and dissertation collection now includes almost 42,000 open access McGill theses and dissertations dating back to 1881. Theses and dissertations are searchable by faculty and department, degree, or subject at escholarship.mcgill.ca. To date almost 7,000 theses have been digitized representing almost a million pages.
You probably know someone who has it. It is the most common movement disorder, yet most people don’t even know its name.
Essential tremor affects nearly one per cent of the world’s population, increasing to four per cent of those over 40. The involuntary shaking of hands is the most common symptom, but symptoms can also include shaking of the head and legs.
The Montreal Neurological Institute and Hospital (The Neuro) is pleased to announce a new initiative designed to ease the suffering of seriously ill patients through specialized consultation and comprehensive care.
The Susan Cameron Cook Neuro-Palliative Care Program, named in honour of Susan Cameron Cook, whose family provided vital seed funding for this initiative, has the goal of reducing the mental and physical suffering of neurological patients and their families in the journey from diagnosis of a terminal illness to end of life.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital at McGill University and the McGill University Health Centre, has been chosen to receive another major award recognizing his outstanding scientific career. The national organization representing Canadian francophone doctors, Médecins francophones du Canada, is bestowing on him its 2016 Prix de l’oeuvre scientifique.
Memorandum
Date: September 26, 2016
To: McGill Researchers, Academic Leadership, and Administrative Staff
Cc: Suzanne Fortier, Principal and Vice-Chancellor
Christopher Manfredi, Provost and Vice-Principal (Academic)
From: Morty Yalovsky, Interim Vice-Principal, Administration and Finance
Rose Goldstein, Vice-Principal, Research and Innovation
Re: Tri-Agency Monitoring Site Visit 2016 Results
A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.
The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.
Research and Innovation (R&I) is pleased to announce the appointment of Prof. Nancy Ross of the Department of Geography as Associate Vice-Principal, Research and Innovation (AVP-R&I), with a three-year mandate beginning September 1, 2016. Prof. Ross follows Prof. Antonia Maioni, who served in the role for one year before assuming the role of Dean of the Faculty of Arts at McGill University on July 1.
Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman
With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.
McGill Newsroom
Chemicals found to improve low-light vision of tadpoles by sensitizing retinal cells
A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
Chemicals shown to improve low-light vision of tadpoles by sensitizing retinal cells
A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
McGill Newsroom
As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.
By James Martin
McGill professors Corinne Maurice and Kieran O’Donnell have been appointed to the CIFAR Azrieli Global Scholars program, a new initiative that helps outstanding early-career researchers develop the leadership and communication skills, and network connections, they’ll need to solve some of our most pressing problems